Cargando…
Challenges in the diagnosis and treatment of CNS demyelinating disorders in Zambia
Demyelinating disease occurs in a population of black adult Zambians whose genetic and environmental risk factors for multiple sclerosis are thought to be rare. The diagnosis of demyelinating disease was based predominantly on compatible clinical history and neurologic exam findings, and in some cas...
Autores principales: | Miskin, Dhanashri P, Saadi, Altaf, Chikoya, Laston, Sloane, Jacob A, Koralnik, Igor J, Siddiqi, Omar K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5433341/ https://www.ncbi.nlm.nih.gov/pubmed/28607733 http://dx.doi.org/10.1177/2055217316657117 |
Ejemplares similares
-
Diagnostic delay in progressive multifocal leukoencephalopathy
por: Miskin, Dhanashri P., et al.
Publicado: (2016) -
Interleukin-7 treatment of PML in a patient with idiopathic lymphocytopenia
por: Miskin, Dhanashri P., et al.
Publicado: (2016) -
Blunted Post-COVID-19 Humoral Immunity in Patients With CNS Demyelinating Disorders on Anti-CD20 Treatments
por: Money, Kelli M., et al.
Publicado: (2022) -
Assessing the short, intermediate and long-term health effects of COVID-19 on the survivors in Zambia: a prospective quantitative study protocol
por: Sialubanje, Cephas, et al.
Publicado: (2022) -
Deciphering the Footprints of Autoimmunity in CNS Demyelinating Disorders
por: Netravathi, M
Publicado: (2022)